Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.20 +0.05 (+3.91%)
As of: Oct 22, 2026 · 12:11 PM EDT

Alx Oncology Holdings (ALXO) EBT Margin (2019 - 2022)

Updated

Alx Oncology Holdings (ALXO) reported EBT Margin of -3849.32% for FY2020, down 3448.80 percentage points from -400.52% in FY2019.

Analysis

Alx Oncology Holdings (ALXO) EBT Margin (2019 - 2022) Analysis & Trends

  • According to Business Quant data, EBT Margin came in at -400.52% in FY2019 (+261.60 pp) and -662.12% in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,170.99 Bn 1,139.58 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 642.25 Bn 560.77 Bn 17.26 Bn 26.66%
3 AbbVie 502.08 Bn 475.19 Bn 12.70 Bn 25.18%
4 Merck 375.61 Bn 329.99 Bn 12.21 Bn -4.11%
5 Novartis Ag 302.76 Bn 266.75 Bn 11.24 Bn 29.63%
6 Astrazeneca 268.66 Bn 242.35 Bn 12.86 Bn 18.19%
7 Amgen 241.98 Bn 197.38 Bn 7.24 Bn 27.53%
8 Gilead Sciences 193.37 Bn 167.57 Bn 6.22 Bn -131.41%
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -4.34%
10 Alx Oncology Holdings 162.09 Mn -221.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1,695.79%
Sep 30, 2022 -2,577.59%
Jun 30, 2022 -3,757.42%
Mar 31, 2022 -10,900.00%
Dec 31, 2021 -135,519.05%
Sep 30, 2021 -111,663.64%
Jun 30, 2021 -70,756.52%
Jun 30, 2020 -2,146.30%
Mar 31, 2020 -832.06%
Dec 31, 2019 -639.32%
Sep 30, 2019 -241.72%
Jun 30, 2019 -323.47%
API Access

Alx Oncology Holdings EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ALXO&period=max&api_key=YOUR_API_KEY